跳至主要内容
临床试验/NCT01581502
NCT01581502Unknown不适用

Stroke Acute Management With Urgent Risk-factor Assessment and Improvement (SAMURAI) Study on Anticoagulant Therapy in Nonvalvular Atrial Fibrillation (NVAF)

Ministry of Health, Labour and Welfare, Japan16 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,000
试验地点
16
主要终点
Ischemic events

研究概览

简要总结

The purpose of this study is to determine choice of anticoagulant therapy during acute and chronic stages of ischemic stroke/TIA and short- and long-term outcomes, including stroke recurrence and bleeding complications, in patients having nonvalvular atrial fibrillation.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Consecutive acute ischemic stroke/TIA patients with NVAF

排除标准

  • Rheumatic mitral valve disease
  • A history of prosthetic valve replacement or mitral valve surgical repair
  • Active infective endocarditis
  • Patient, family member or legally responsible person does not have given informed consent
  • Inappropriate patient's conditions for study enrollment in the opinion of the investigator

结局指标

主要结局

Ischemic events

时间窗: 2 years

Recurrence of ischemic stroke/TIA, ACS, systemic embolism, aortic dissection, rupture of aortic aneurysm, peripheral artery disease (required hospitalization), VTE, revascularization (including CEA/CAS, PCI, etc)

major bleeding

时间窗: 2 years

Major bleeding according to the ISTH definition, including fatal bleeding, intracranial hemorrhage, etc

次要结局

  • modified Rankin Scale(2 years)
  • Modification of anticoagulant medication(2 years)

研究者

发起方
Ministry of Health, Labour and Welfare, Japan
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Kazunori Toyoda

National Cerebral and Cardiovascular Center

Ministry of Health, Labour and Welfare, Japan

研究点 (16)

Loading locations...

相似试验

SAMURAI-NVAF Study: Anticoagulant Therapy for... | 临床试验